The regulatory role of human TACI-Fc fusion protein to XG6 cell line in vitro

Chinese Journal of Microbiology and Immunology

Volumn 25, Issue 11, 2005, Pages 912-916

  Xu, Hai Yan ^a   Wang, Yong ^a   Yu, Ge Hua ^a   Ma, Hong Bing ^a   Xu, Ying ^a   Shi, Qin ^a   Zhang, Xue Guang ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Proliferation; TACI Fc fusion protein; Transfectant cell

Indexed keywords

COMPLEMENTARY DNA; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; MEMBRANE PROTEIN; PROTEIN G; TRANSMEMBRANE ACTIVATOR AND CALCIUM MODULATOR AND CYCLOPHILIN LIGAND INTERACTOR; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; AFFINITY CHROMATOGRAPHY; ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; GENE AMPLIFICATION; GENE INSERTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR CLONING; RECOMBINANT PLASMID; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; TONSIL CELL;

EID: 32344441139     PISSN: 02545101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Wu YM, Bressette D, Carrell JA, et al. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS. JBC, 2000, 275(10): 35478-35485.
2. Xia XZ, Treanor J, Senaldi G, et al. TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation. J Exp Med, 2000, 192: 137-143.
3. Seshasayee D, Valdec P, Yan M, et al. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory Blys receptor. Immunity, 2003, 18: 279-288.
4. von Bulow GU, van Deursen JM, Bram RJ. Regulation of the T-independent humoral response by TACI. Immunity, 2001, 14: 573-582.
5. Hahne M, Kataoka T, Schroter M, et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med, 1998, 188: 1185-1190.
6. Zhang XG, Gaillard JP, Robillard N, et al. Reproducible obtaining of human myeloma cell lines as a model for turner stem cell study in human multiple myeloma. Blood, 1994, 83: 3654-3663.
7. Novak AJ, Darce JR, Arendt BK, et al. Expression of BCMA, TACI and BAFF-R in multiple myeloma: a mechanism for growth and survival. Blood, 2004, 103: 689-694.
8. Moreaux J, Legouffe E, Jourdan E, et al. BAFF and APRIL protect myeloma cells from apoptosis induced by IL-6 deprivation and dexamethasone. Blood, 2004, 103: 3148-3157.
9. He B, Chadburn A, Jou E, et al. Lymphoma B cells evade apoptosis through the TNF family members BAFF/Blys and APRIL. J Immunol, 2004, 172: 3268-3279.
10. Stohl W. SLE-systemic lupus erythematosus: a Blysful, yet BAFFling disorder. Arthritis Res, 2003, 5(3): 136-138.
11. Ye QR, Wang LQ, Wells AD, et al. BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses. Eur J Immunol, 2004, 34: 2750-2759.
12. Ramanujam M, Wang X, Huang W, et al. Mechanism of action of transmembrane activator and calcium modulator ligand interator-Ig in murine systemic lupus erythematosus. J Immunol, 2004, 173: 3524-3534.